Nicacio Leonardo Viana has filed 4 insider transactions across 1 company since April 2025.
Most recent transaction: a grant/award of 26000 shares of Protara Therapeutics, Inc. ($PRTO) on January 16, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 16, 2026 | Protara Therapeutics, Inc. | $PRTO | Nicacio Leonardo Viana | Chief Medical Officer | A | Common Stock | 26000 | $0.00 | 78,181.0000 | 42,272,104 | 49.83% | 0.06% |
| Jan. 16, 2026 | Protara Therapeutics, Inc. | $PRTO | Nicacio Leonardo Viana | Chief Medical Officer | A | Stock Option (Right to Buy) | 158000 | $0.00 | 158,000.0000 | 42,272,104 | 9999.99% | 0.37% |
| April 15, 2025 | Protara Therapeutics, Inc. | $PRTO | Nicacio Leonardo Viana | Chief Medical Officer | A | Common Stock | 50000 | $0.00 | 52,181.0000 | 40,707,937 | 2292.53% | 0.12% |
| April 15, 2025 | Protara Therapeutics, Inc. | $PRTO | Nicacio Leonardo Viana | Chief Medical Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 40,707,937 | 9999.99% | 0.37% |